Here’s why Soligenix, Inc. (SNGX) stock is Popping High today
Soligenix, Inc. (SNGX) stock gained Pediatric Investigation Plan (PIP) waiver for HyBryte™ (SGX301 or hypericin) by European Medicines Agency (EMA) after which the SNGX stock price saw an uptrend of 10.26% to reach $1.29 a share at the time of this writing. The stock went high in the previous trading session following the receival of […]